Whalesbook
Lord's Mark Industries has achieved a significant milestone with its approval from the Bombay Stock Exchange (BSE) to list under the Indian insolvency framework. This listing was made possible by using the Pre-Packaged Insolvency Resolution Process (PPIRP), which allowed the company to bypass the lengthier traditional Corporate Insolvency Resolution Process (CIRP).
The company, classified as a Micro, Small, and Medium Enterprise (MSME), benefited from a debtor-in-possession approach under the PPIRP. The resolution plan, approved by the National Company Law Tribunal (NCLT) in July 2025, involved a reverse merger with Kratos Energy & Infrastructure Ltd. This effectively provided a backdoor listing, helping to preserve the company's value while addressing legacy debts.
This listing is the outcome of a multi-year strategy to shift from trading to manufacturing, focusing on renewable energy, diagnostics, and medical technology. Managing Director Sachidanand Upadhyay has led the expansion into these capital-intensive areas. The restructuring included a 1:1.25 share swap ratio to unify the group's structure. Successfully clearing creditor claims, a major issue for Kratos Energy previously, was crucial for meeting exchange listing rules.
While the BSE approval is a positive step, historical concerns regarding Lord's Mark Industries' regulatory compliance and transparency, particularly in filing annual disclosures, suggest caution. Reverse mergers can sometimes obscure operational issues from the acquired entity. Investors should carefully assess the company's business viability alongside its legal navigation of the IBC. The company's diverse product lines span EV infrastructure to diagnostics, and high leverage in restructurings can lead to future equity dilution.
Trading is expected to start in June 2026, serving as the first market test for the reorganized company. Management plans to seek listing on the National Stock Exchange (NSE) within the next year. The company's long-term success hinges on executing its expansion in Medtech and renewable energy without repeating debt challenges, as the PPIRP offers a unique chance for a fresh financial start.